FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2035854913> ?p ?o ?g. }

• W2035854913 endingPage "111" @default.
• W2035854913 startingPage "101" @default.
• W2035854913 abstract "Co-activation of NMDA and dopamine receptors is required for the induction of the late phase of LTP (L-LTP) that is dependent on new protein synthesis. Other neuromodulatory substances may also contribute to this process. Here, we examined whether taurine is one of the neuromodulators contributing to L-LTP induction, since it is known that taurine uptake induces a long-lasting synaptic potentiation dependent on protein synthesis, and taurine uptake inhibition blocks L-LTP induced by tetanization. Experiments were conducted using rat hippocampal slices where field synaptic potentials were evoked and recorded in CA3-CA1 synapses. Taurine (1 mM) applied 10 min before a high frequency stimulation (HFS) train converted a transitory early-LTP (E-LTP) into an L-LTP dependent on protein synthesis. This taurine effect was blocked by a taurine uptake inhibitor. A facilitation of L-LTP induction was also obtained by pre-application of SKF38393, a D1/D5 dopamine receptor (D1R) agonist. In this case, LTP facilitation was not affected by the taurine uptake inhibitor. Nevertheless, when taurine and SKF38393 were simultaneously pre-applied at a concentration that individually did not modify E-LTP, they produced a synergistic mechanism that facilitated the induction of L-LTP with a sole HFS train. This facilitation of L-LTP was blocked by inhibiting either taurine uptake or D1R activation. Taurine and SKF38393 activated different signaling pathways to transform E-LTP into L-LTP. Taurine-induced L-LTP facilitation required MAPK activation, while D1R-agonist-induced facilitation depended mainly on PKA activation and partially on MAPK activation. On the other hand, the synergistic mechanisms induced by the cooperative action of taurine and SKF38393 were impaired by inhibitors against MAPK, PKA and PI3-K. This pharmacological profile resembles that displayed by L-LTP induced by three HFS trains at 10-min intervals. These results indicate that taurine uptake is necessary and cooperates with other neurotransmitter systems in the induction of L-LTP." @default.
• W2035854913 created "2016-06-24" @default.
• W2035854913 creator A5012087839 @default.
• W2035854913 creator A5031540972 @default.
• W2035854913 creator A5038108795 @default.
• W2035854913 creator A5041846355 @default.
• W2035854913 creator A5048790602 @default.
• W2035854913 date "2014-04-01" @default.
• W2035854913 modified "2023-09-24" @default.
• W2035854913 title "Cooperation of taurine uptake and dopamine D1 receptor activation facilitates the induction of protein synthesis-dependent late LTP" @default.
• W2035854913 cites W1501143146 @default.
• W2035854913 cites W1515701659 @default.
• W2035854913 cites W1553096643 @default.
• W2035854913 cites W1605885510 @default.
• W2035854913 cites W1670445830 @default.
• W2035854913 cites W1937085587 @default.
• W2035854913 cites W1964486755 @default.
• W2035854913 cites W1969595491 @default.
• W2035854913 cites W1969825283 @default.
• W2035854913 cites W1972326540 @default.
• W2035854913 cites W1973533307 @default.
• W2035854913 cites W1979548918 @default.
• W2035854913 cites W1982296173 @default.
• W2035854913 cites W1990264946 @default.
• W2035854913 cites W1991942710 @default.
• W2035854913 cites W1992084781 @default.
• W2035854913 cites W1993093866 @default.
• W2035854913 cites W1999903081 @default.
• W2035854913 cites W2002927748 @default.
• W2035854913 cites W2003381464 @default.
• W2035854913 cites W2012417073 @default.
• W2035854913 cites W2014050156 @default.
• W2035854913 cites W2015105837 @default.
• W2035854913 cites W2018662966 @default.
• W2035854913 cites W2020440721 @default.
• W2035854913 cites W2020969390 @default.
• W2035854913 cites W2022086637 @default.
• W2035854913 cites W2028386191 @default.
• W2035854913 cites W2030857678 @default.
• W2035854913 cites W2039086898 @default.
• W2035854913 cites W2041251386 @default.
• W2035854913 cites W2043572621 @default.
• W2035854913 cites W2045441934 @default.
• W2035854913 cites W2051473177 @default.
• W2035854913 cites W2062793711 @default.
• W2035854913 cites W2069705491 @default.
• W2035854913 cites W2071073423 @default.
• W2035854913 cites W2074650516 @default.
• W2035854913 cites W2076314939 @default.
• W2035854913 cites W2082665903 @default.
• W2035854913 cites W2082757053 @default.
• W2035854913 cites W2091339773 @default.
• W2035854913 cites W2093522308 @default.
• W2035854913 cites W2096081604 @default.
• W2035854913 cites W2107688359 @default.
• W2035854913 cites W2128134322 @default.
• W2035854913 cites W2133083344 @default.
• W2035854913 cites W2140597415 @default.
• W2035854913 cites W2155021051 @default.
• W2035854913 cites W2161070224 @default.
• W2035854913 cites W2169471345 @default.
• W2035854913 doi "https://doi.org/10.1016/j.neuropharm.2013.10.035" @default.
• W2035854913 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24225198" @default.
• W2035854913 hasPublicationYear "2014" @default.
• W2035854913 type Work @default.
• W2035854913 sameAs 2035854913 @default.
• W2035854913 citedByCount "11" @default.
• W2035854913 countsByYear W20358549132015 @default.
• W2035854913 countsByYear W20358549132016 @default.
• W2035854913 countsByYear W20358549132017 @default.
• W2035854913 countsByYear W20358549132018 @default.
• W2035854913 countsByYear W20358549132019 @default.
• W2035854913 countsByYear W20358549132022 @default.
• W2035854913 crossrefType "journal-article" @default.
• W2035854913 hasAuthorship W2035854913A5012087839 @default.
• W2035854913 hasAuthorship W2035854913A5031540972 @default.
• W2035854913 hasAuthorship W2035854913A5038108795 @default.
• W2035854913 hasAuthorship W2035854913A5041846355 @default.
• W2035854913 hasAuthorship W2035854913A5048790602 @default.
• W2035854913 hasConcept C112592302 @default.
• W2035854913 hasConcept C169760540 @default.
• W2035854913 hasConcept C170493617 @default.
• W2035854913 hasConcept C185592680 @default.
• W2035854913 hasConcept C25274449 @default.
• W2035854913 hasConcept C2776328245 @default.
• W2035854913 hasConcept C2778938600 @default.
• W2035854913 hasConcept C2779701627 @default.
• W2035854913 hasConcept C513476851 @default.
• W2035854913 hasConcept C515207424 @default.
• W2035854913 hasConcept C55493867 @default.
• W2035854913 hasConcept C67018056 @default.
• W2035854913 hasConcept C86803240 @default.
• W2035854913 hasConceptScore W2035854913C112592302 @default.
• W2035854913 hasConceptScore W2035854913C169760540 @default.
• W2035854913 hasConceptScore W2035854913C170493617 @default.
• W2035854913 hasConceptScore W2035854913C185592680 @default.
• W2035854913 hasConceptScore W2035854913C25274449 @default.
• W2035854913 hasConceptScore W2035854913C2776328245 @default.

• next